Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary prevention

J Am Coll Cardiol. 2008 Apr 1;51(13):1255-7. doi: 10.1016/j.jacc.2008.01.004.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Cardiovascular Agents / therapeutic use*
  • Female
  • Humans
  • Hypolipidemic Agents / therapeutic use
  • Length of Stay
  • Male
  • Myocardial Infarction / mortality*
  • Myocardial Infarction / physiopathology
  • Myocardial Infarction / prevention & control*
  • Patient Discharge
  • Prognosis
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Cardiovascular Agents
  • Hypolipidemic Agents